Brief: Shandong Weigao Group Medical Polymer Says Wang Yi Re-Designated To Executive Director
14/03/2019 10:32
March 14 (Reuters) - Shandong Weigao Group Medical Polymer
Co Ltd 1066.HK :
* WANG YI RE-DESIGNATED FROM A NON- EXECUTIVE DIRECTOR TO AN
EXECUTIVE DIRECTOR
Source text for Eikon: urn:newsml:reuters.com:*:nHKS1vwjXQ
Further company coverage: 1066.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Shandong Weigao Medical Polymer
See all newsChina's Weigao H1 profit falls 23% as price drops, competition hit margins
Brief: Shandong Weigao Group Medical Polymer H1 Net Income Attributable RMB 890.4 Mln
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 11.4 Million H Shares From 15 May 2026 To June 5
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 3.6 Million H Shares
Brief: Shandong Weigao Group Medical Polymer Says Unit To Establish Fund Of KRW52.965 Billion